OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $155,300 Invested

2009

University of Rochester

Rashid Deane, PhD

Early toxicology and ADME studies with our lead RAGE inhibitors

  • Funding Amount: $155,300
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed